The New England Journal of Medicine
published the work of Jennifer Woyach, MD ‘05, associate professor of
Hematology. And at the American Society of Hematology annual meeting, Dr.
Woyach presented the results of her study, Ibrutinib Regimens versus
Chemoimmunotherapy in Older Patients with Untreated Chronic Lymphocytic
Leukemia (CLL), which change the standard of care for the treatment of older
patients with CLL.